Meta-analysis | Number of patients analyzed | RR or HR for DOACs versus LMWH (95% CI) | ||
---|---|---|---|---|
VTE recurrence | Major bleeding | CNRMB | ||
Mulder, et al.a (59) | 2607 | 0.68 (0.39–1.17) | 1.36 (0.55–3.35) | 1.63 (0.73–3.64) |
Giustozzi et al.b (39) | 2894 | 0.62 (0.43–0.91) | 1.31 (0.83–2.08) | 1.51 (1.09–2.09) |
Moik, et al.b (58) | 2894 | 0.62 (0.43–0.91) | 1.31 (0.83–2.08) | 1.65 (1.19–2.28) |
Tao, et al.b (61) | 2894 | 0.62 (0.43–0.91) | 1.31, (0.83–2.08) | 1.65 (1.19–2.28) |
Haykal, et al.b (57) | 2907 | 0.62 (0.44–0.87) | 1.33 (0.45–4.22) | 1.58 (1.11–2.24) |
Saleem, et al.b (60) | 2907 | 0.54 (0.23–1.28) | 1.38 (0.45–4.22) | 1.77 (0.49–6.40) |